Accent Therapeutics, Inc.  logo

Accent Therapeutics, Inc.

Leading the translation of RNA-modifying protein (RMP) biology into promising new therapies for cancer

55 employees · est. 2017 · Lexington, United States

VS
Probiomedica logo

Probiomedica

Probiomedica develops innovative health devices using engineering, biology, photonics, and robotics.

est. 2015

Probiomedica is the older company (2017 vs 2015).

Side-by-Side Comparison

Accent Therapeutics, Inc. Probiomedica
Founded
2017 2015 older
Headquarters
Lexington, United States Not tracked yet
Employees
55 Not tracked yet
Industry
Biotechnology, Health and Wellness, Pharmaceutical Not tracked yet
Funding Stage
Series C Grant
Total Funding
$178.00M $71.43K
Funding Rounds
3 1
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
RNA-modifying Protein, RMP Biology, Cancer Therapies, Chemical Biology Platform, Target Identification, Drug Development, Small Molecule Therapies Biomedical Devices, Engineering, Biology, Photonics, Robotics, Photo-therapies, Health Devices, Innovation, Personal Well-being
Website
accenttx.com probiomedica.it
Accent Therapeutics, Inc.  logo

About Accent Therapeutics, Inc.

Accent Therapeutics, Inc. is a biotechnology and pharmaceutical company founded in 2017 and headquartered in the United States. The company is dedicated to leading the translation of RNA-modifying protein (RMP) biology into promising new therapies for cancer. With a robust chemical biology platform...

Probiomedica logo

About Probiomedica

Probiomedica is an innovative startup that focuses on creating advanced health devices by integrating engineering, biology, photonics, and robotics. With the slogan "Probiomedica develops innovative health devices using engineering, biology, photonics, and robotics," the company is committed to pion...

We will tell you when either one moves

BounceWatch watches Accent Therapeutics, Inc. and Probiomedica for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Accent Therapeutics, I... and Probiomedica — by email.

Frequently Asked Questions

Accent Therapeutics, Inc. — Leading the translation of RNA-modifying protein (RMP) biology into promising new therapies for cancer. Probiomedica — Probiomedica develops innovative health devices using engineering, biology, photonics, and robotics.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Accent Therapeutics, Inc. has raised $178.00M while Probiomedica has raised $71.43K.
Accent Therapeutics, Inc. and Probiomedica operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Accent Therapeutics, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Accent Therapeutics, Inc. on 12 Sep 2024, and Probiomedica on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy